Not a good buy right now for an impatient entry: price is pressing into near-term resistance (R1 ~129.06) after a +2.94% regular-session move, while the broader trend (SMA200 > SMA20 > SMA5) is still bearish.
Near-term momentum is improving (MACD histogram >0 and expanding; RSI ~65), but the setup looks closer to a breakout test than a low-risk entry.
Better risk/reward would come on either (a) a clean breakout and hold above ~129–131, or (b) a pullback toward the pivot ~125.5; today’s level is neither.
Trend: Mixed-to-bearish overall due to moving-average stack (SMA200 > SMA20 > SMA5), suggesting the longer trend still points down despite the recent bounce.
RSI: RSI_6 = 64.955 (neutral-to-warm), not overbought but getting closer to the upper range.
Key levels: Pivot 125.516; Resistance R1 129.056 and R2 131.243; Support S1 121.977 and S2 119.79.
Tactical read: With price ~128.6 (just under R1), upside may require a decisive breakout; otherwise, rejection risk increases near resistance.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/Sentiment: Put-call ratios below 1 (OI 0.79; volume 0.5) lean bullish (more call interest/flow vs puts), but today’s absolute volume is extremely low (total volume 3), so the signal is weak.
Volatility: 30D IV 37.64 vs historical vol 21.92; IV percentile 74.5 suggests options are relatively expensive right now (market pricing higher uncertainty).
Liquidity/flow: Today vs 30D average volume shows 75 (reported), but given tiny absolute volume, interpret cautiously; open interest is small (calls 209, puts 165).
Technical Summary
Sell
6
Buy
9
Positive Catalysts
Improving momentum indicators (MACD strengthening) and bullish-leaning put/call ratios may support a near-term push through resistance if buyers follow through.
Financial momentum is strong (notably profit and EPS growth), which can attract incremental buyers on dips.
Pattern-based outlook provided indicates potential upside probabilities over week/month horizons (as given by the dataset).
Net income: 76,420,000 (+38.31% YoY) — strong profitability acceleration.
EPS: 2.48 (+37.78% YoY) — robust earnings growth.
Gross margin: 44.4 (+9.74% YoY) — improving margins support the earnings expansion.
Takeaway: Fundamentals are clearly improving, but the current entry point is constrained more by technical positioning near resistance than by weak business performance.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating/price-target change data was provided in the dataset, so a recent trend summary cannot be confirmed.
Wall Street pros (inferred from financials): accelerating EPS and margin expansion support a constructive fundamental view.
Wall Street cons (inferred from tape/positioning): trend confirmation is lacking on longer-term technicals; without fresh catalysts or visible estimate/target revisions, upside may be more incremental than immediate.
Wall Street analysts forecast DORM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DORM is 174.25 USD with a low forecast of 150 USD and a high forecast of 185 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast DORM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DORM is 174.25 USD with a low forecast of 150 USD and a high forecast of 185 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 128.620
Low
150
Averages
174.25
High
185
Current: 128.620
Low
150
Averages
174.25
High
185
Stephens
Jeff Lick
initiated
$185
AI Analysis
2025-09-29
Reason
Stephens
Jeff Lick
Price Target
$185
AI Analysis
2025-09-29
initiated
Reason
Stephens analyst Jeff Lick initiated coverage of Dorman Products with an Overweight rating and $185 price target. The maker of aftermarket auto parts is a secular growth story that benefits from the decline of auto affordability, an aging car park and the array of different propulsion systems \"caused by there being no clear-cut winner,\" the analyst tells investors. The firm, which also sees Dorman as a net tariff beneficiary, vies the the stock as \"relatively undiscovered and under owned\" despite the company's $4.8B market cap and shares trading near all-time highs, the analyst added.
BMO Capital
Tristan Thomas-Martin
Outperform
initiated
$180
2025-09-18
Reason
BMO Capital
Tristan Thomas-Martin
Price Target
$180
2025-09-18
initiated
Outperform
Reason
BMO Capital analyst Tristan Thomas-Martin initiated coverage of Dorman Products with an Outperform rating and $180 price target. The firm sees further upside in the shares given the resiliency of the company's core, light-vehicle business in a challenging macroeconomic environment. Dorman is a leading supplier of replacement and upgrade parts in the motor vehicle aftermarket industry, and has recently expanded into the heavy-duty and specialty vehicle markets, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for DORM
